The North America Autoinjectors Market would witness market growth of 16.9% CAGR during the forecast period (2020-2026). As per the US National Health Council, approximately 75% of the healthcare expenditure of the nation is used in the treatment of chronic diseases, including diabetes. The main share of expenditures is acquired by patients who are living with a chronic disorder is compelled by the regular need to get medicated, which may necessitate repeated visits to either hospitals or out-patient clinics.
With time, a range of solutions that enable self-administration of drugs has been developed and presented into the market. In a reasonably short time period, the market for self-injection devices has full-fledged into a conspicuous and promising segment in the pharmaceutical industry. Autoinjectors are one such device that has witnessed amplified adoption among patients, particularly for the treatment of emergency situations like anaphylactic shocks. As per the developers, these devices are quite easier to use as compared to parenteral drug delivery systems and have incorporated needle-safety features. It has been proved that the autoinjectors have resolved a number of issues faced by patients such as injection-related tolerability.
Market growth is mainly driven by the increasing incidences of targeted therapies, the increasing occurrence of anaphylaxis, growing inclination for self-administration of drugs. Further, the usability benefits, the growing number of governing approvals, and the accessibility of standard versions of autoinjectors, favorable settlements pertaining to the autoinjectors is fuelling the market. In addition, government’s provision as well as technological advancements are likely to turn this market more opportunistic. The patent termination of biologics is also anticipated to deliver growth opportunities for the market.
Based on Type, the market is segmented into Disposable autoinjectors and Reusable autoinjectors. Based on Application, the market is segmented into Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis and other Applications. Based on End Use, the market is segmented into Hospitals & Clinics and Home care settings. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Autoinjectors Market in North America is expected to register a CAGR of 16.9% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly and Company, GlaxoSmithKline PLC (GSK), Merck Group, Sanofi S.A., Becton, Dickinson and Company, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., Ypsomed AG, AbbVie, Inc. and Biogen, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Disposable autoinjectors
- Reusable autoinjectors
By Application
- Anaphylaxis
- Rheumatoid Arthritis
- Multiple Sclerosis
- Other Applications
By End Use
- Hospitals & Clinics
- Home care settings
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Eli Lilly and Company
- GlaxoSmithKline PLC (GSK)
- Merck Group
- Sanofi S.A.
- Becton, Dickinson and Company
- Teva Pharmaceuticals Industries Ltd.
- Amgen, Inc.
- Ypsomed AG
- AbbVie, Inc.
- Biogen, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Autoinjectors Market, by Type
1.4.2 North America Autoinjectors Market, by Application
1.4.3 North America Autoinjectors Market, by End Use
1.4.4 North America Autoinjectors Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May – 2020, Nov) Leading Players
Chapter 4. North America Autoinjectors Market by Type
4.1 North America Disposable autoinjectors Market by Country
4.2 North America Reusable autoinjectors Market by Country
Chapter 5. North America Autoinjectors Market by Application
5.1 North America Anaphylaxis Market by Country
5.2 North America Rheumatoid Arthritis Market by Country
5.3 North America Multiple Sclerosis Market by Country
5.4 North America Other Application Market by Country
Chapter 6. North America Autoinjectors Market by End Use
6.1 North America Hospitals & Clinics Autoinjectors Market by Country
6.2 North America Home care settings Autoinjectors Market by Country
Chapter 7. North America Autoinjectors Market by Country
7.1 US Autoinjectors Market
7.1.1 US Autoinjectors Market by Type
7.1.2 US Autoinjectors Market by Application
7.1.3 US Autoinjectors Market by End Use
7.2 Canada Autoinjectors Market
7.2.1 Canada Autoinjectors Market by Type
7.2.2 Canada Autoinjectors Market by Application
7.2.3 Canada Autoinjectors Market by End Use
7.3 Mexico Autoinjectors Market
7.3.1 Mexico Autoinjectors Market by Type
7.3.2 Mexico Autoinjectors Market by Application
7.3.3 Mexico Autoinjectors Market by End Use
7.4 Rest of North America Autoinjectors Market
7.4.1 Rest of North America Autoinjectors Market by Type
7.4.2 Rest of North America Autoinjectors Market by Application
7.4.3 Rest of North America Autoinjectors Market by End Use
Chapter 8. Company Profiles
8.1 Eli Lilly and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Geographical Expansions:
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.1 Recent strategies and developments:
8.2.1.1 Approvals:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Sanofi S.A.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Approvals:
8.4.5.3 Product Launches and Product Expansions:
8.5 Becton, Dickinson and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Approvals:
8.7 Amgen, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Research & Development Expense
8.7.4 Recent strategies and developments:
8.7.4.1 Product Launches and Product Expansions:
8.8 Ypsomed AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 AbbVie, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.10. Biogen, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
TABLE 1 North America Autoinjectors Market, 2016 - 2019, USD Million
TABLE 2 North America Autoinjectors Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Auto-Injectors Market
TABLE 4 Product Launches And Product Expansions– Auto-Injectors Market
TABLE 5 Geographical Expansions– Auto-Injectors Market
TABLE 6 Approvals– Auto-Injectors Market
TABLE 7 North America Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 8 North America Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 9 North America Disposable autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 10 North America Disposable autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 11 North America Reusable autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 12 North America Reusable autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 13 North America Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 14 North America Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 15 North America Anaphylaxis Market by Country, 2016 - 2019, USD Million
TABLE 16 North America Anaphylaxis Market by Country, 2020 - 2026, USD Million
TABLE 17 North America Rheumatoid Arthritis Market by Country, 2016 - 2019, USD Million
TABLE 18 North America Rheumatoid Arthritis Market by Country, 2020 - 2026, USD Million
TABLE 19 North America Multiple Sclerosis Market by Country, 2016 - 2019, USD Million
TABLE 20 North America Multiple Sclerosis Market by Country, 2020 - 2026, USD Million
TABLE 21 North America Other Application Market by Country, 2016 - 2019, USD Million
TABLE 22 North America Other Application Market by Country, 2020 - 2026, USD Million
TABLE 23 North America Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 24 North America Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 25 North America Hospitals & Clinics Autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 26 North America Hospitals & Clinics Autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 27 North America Home care settings Autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 28 North America Home care settings Autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 29 North America Autoinjectors Market by Country, 2016 - 2019, USD Million
TABLE 30 North America Autoinjectors Market by Country, 2020 - 2026, USD Million
TABLE 31 US Autoinjectors Market, 2016 - 2019, USD Million
TABLE 32 US Autoinjectors Market, 2020 - 2026, USD Million
TABLE 33 US Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 34 US Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 35 US Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 36 US Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 37 US Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 38 Canada Autoinjectors Market, 2016 - 2019, USD Million
TABLE 39 Canada Autoinjectors Market, 2020 - 2026, USD Million
TABLE 40 Canada Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 41 Canada Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 42 Canada Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 43 Canada Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 44 Canada Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 45 Canada Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 46 Mexico Autoinjectors Market, 2016 - 2019, USD Million
TABLE 47 Mexico Autoinjectors Market, 2020 - 2026, USD Million
TABLE 48 Mexico Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 49 Mexico Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 50 Mexico Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 51 Mexico Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 52 Mexico Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 53 Mexico Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 54 Rest of North America Autoinjectors Market, 2016 - 2019, USD Million
TABLE 55 Rest of North America Autoinjectors Market, 2020 - 2026, USD Million
TABLE 56 Rest of North America Autoinjectors Market by Type, 2016 - 2019, USD Million
TABLE 57 Rest of North America Autoinjectors Market by Type, 2020 - 2026, USD Million
TABLE 58 Rest of North America Autoinjectors Market by Application, 2016 - 2019, USD Million
TABLE 59 Rest of North America Autoinjectors Market by Application, 2020 - 2026, USD Million
TABLE 60 Rest of North America Autoinjectors Market by End Use, 2016 - 2019, USD Million
TABLE 61 Rest of North America Autoinjectors Market by End Use, 2020 - 2026, USD Million
TABLE 62 Key Information – Eli Lilly and Company
TABLE 63 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 64 key Information – Merck Group
TABLE 65 Key Information – Sanofi S.A.
TABLE 66 Key information – Becton, Dickinson and Company
TABLE 67 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 68 Key Information – Amgen, Inc.
TABLE 69 Key Information –-Ypsomed AG
TABLE 70 Key information – AbbVie, Inc.
TABLE 71 Key Information – Biogen, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, May – 2020, Nov) Leading Players
FIG 5 Recent strategies and developments: Eli Lilly and Company
FIG 6 Recent strategies and developments: Sanofi S.A.
FIG 7 Recent strategies and developments: Becton, Dickinson and Company
FIG 8 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.